Biomarkers In Drug Discovery & Development 2012, 10-11 September, Berlin, Germany

Biomarkers In Drug Discovery & Development 2012, 10-11 September, Berlin, Germany

Main Category: Conferences
Article Date: 04 Jul 2012 - 9:00 PDT

email to a friend   printer friendly   opinions   <!-- rate article
Patient / Public:

Healthcare Prof:

At this specific event participants will meet eminent representatives from big pharma companies such as Pfizer, Sanofi, Bayer, Janssen, Novartis as well as highly qualified experts from academia and research institutes. They are enthusiastic about sharing their knowledge, experience and practices and provide further advices and fresh ideas to their business peers.

The discussion topics will be focused mainly on:

• The latest technologies for biomarker identification
• Methods to discover robust biomarkers for pharmacodynamic and predictive purposes
• Contribution of imaging to decision-making in drug development
• Successful application of biomarkers in various therapeutic areas - moving towards a personalized medicine approach

In order to get deeper into the discussed topics and look at the burning issues from different angles, presentations will be complemented with real-life case studies and interactive sessions. Practical round table discussions beginning with short brainstorming sessions will allow participants to categorize the brainstorming feedback into main discussion topics, and provide the attendees the opportunity to choose a round table discussion that best fits their interest.

This conference is designed for:
Senior Vice Presidents, Chief Scientific Officers, Vice Presidents, Heads, Directors, Scientists, Researchers, Investigators, Professors in:
Biomarkers, Clinical Research, Drug Discovery and Development, Translational Research / Science / Imaging, Molecular Imaging, Experimental Medicine, Clinical Pharmacology, Molecular Toxicology, "Omics" Programmes, Clinical Discovery Technologies, Diagnostics, Biomarker Strategy, Assay Development, Pathway Analysis, Regulatory Affairs, etc.

Are you interested in exploring the best practices in accelerating the identification of drug targets, reducing the overall costs of the drug development process as well as the likelihood of adverse events? Do you want to seize the opportunity to gain strategic contacts and valuable information? Then do not hesitate and join us in Berlin.

Organized by Fleming Europe:
Biomarkers in Drug Discovery Development 2012
10-11 September 2012
Berlin, Germany

Learn more at http://pharma.flemingeurope.com/biomarkers

• Additional
• References
• Citations

About Fleming Europe

Established in Slovakia, Fleming Europe represents a Pan-European B2B networking channel for specialists to collect share knowledge. Since 2004, the company has been encouraging decision makers to share their experiences through market leading conferences, trainings and webinars. The annual audience of 10,000 Banking, Defense, Energy, Oil Gas, Pharma, Telco and Transport peers benefit from insights on industry trends when applying them to their own business practices.

For more information visit http://www.flemingeurope.com

Contact:
Andrea Weber
Marketing Manager
Fleming Europe
Bratislava, Slovak Republic
Tel: +421 257 272 335
Fax: +421 255 644 490
andrea.weber (at) flemingeurope.com

Please use one of the following formats to cite this article in your essay, paper or report:

MLA

---

APA

---

Please note: If no author information is provided, the source is cited instead.

---

Add Your Opinion On This Article

'Biomarkers In Drug Discovery Development 2012, 10-11 September, Berlin, Germany'

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.

Privacy Policy | Terms and Conditions

MediLexicon International Ltd
Bexhill-on-Sea, United Kingdom
MediLexicon International Ltd © 2004-2012 All rights reserved.
MNT (logo) is the registered EU trade mark of MediLexicon Int. Limited.

back to top | home | privacy policy

MediLexicon International Ltd
Bexhill-on-Sea, United Kingdom
MediLexicon International Ltd © 2004-2012 All rights reserved.
MNT (logo) is the registered EU trade mark of MediLexicon Int. Limited.